Activist investor Starboard Value has acquired a $1 billion stake in pharmaceutical giant Pfizer, with the intention of improving the company's performance post-pandemic. Pfizer's stock has fallen over 50% since its pandemic height, mainly attributed to the decrease in demand for its COVID-19 products after the pandemic's peak, and the move by Starboard aims at bringing fresh ideas and potential new leadership to revitalize the veteran company.
It seems that even the big pharma giants need a little nudge every now and then. Activist investor Starboard Value, known for shaking things up in companies that have lost their sparkle, has taken a significant stake in Pfizer—about $1 billion, to be exac...
Subscribe now for $199 and get unlimited access to MYCPE ONE, from CPE credits to insights Magazine
📢MYCPE ONE Insights has a newsletter on LinkedIn as well! If you want the sharpest analysis of all accounting and finance news without the jargon, Insights is the place to be! Click Here to Join
Unlock Annual Access to News & CPE Subscription
You’ve reached the 3 free-content piece limit. Unlock unlimited access to all News & CPE resources. Subscribe Today.
Experience MYCPE ONE at its best! Upgrade your browser for a more interactive, user-friendly interface, and stay ahead in your professional development journey.